ZELTIQ Aesthetics (ZELTIQ Aesthetics) Debt-to-Equity : 0.00 (As of Dec. 2016)

View and export this data going back to 2011. Start your Free Trial

What is ZELTIQ Aesthetics Debt-to-Equity?

ZELTIQ Aesthetics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2016 was $0.0 Mil. ZELTIQ Aesthetics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2016 was $0.0 Mil. ZELTIQ Aesthetics's Total Stockholders Equity for the quarter that ended in Dec. 2016 was $137.7 Mil. ZELTIQ Aesthetics's debt to equity for the quarter that ended in Dec. 2016 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for ZELTIQ Aesthetics's Debt-to-Equity or its related term are showing as below:

ZLTQ's Debt-to-Equity is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.21
* Ranked among companies with meaningful Debt-to-Equity only.

ZELTIQ Aesthetics Debt-to-Equity Historical Data

The historical data trend for ZELTIQ Aesthetics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZELTIQ Aesthetics Debt-to-Equity Chart

ZELTIQ Aesthetics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Debt-to-Equity

Get a 7-Day Free Trial

0.01

ZELTIQ Aesthetics Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ZELTIQ Aesthetics's Debt-to-Equity

For the Medical Devices subindustry, ZELTIQ Aesthetics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ZELTIQ Aesthetics's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ZELTIQ Aesthetics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where ZELTIQ Aesthetics's Debt-to-Equity falls into.

ZELTIQ Aesthetics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

ZELTIQ Aesthetics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2016 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	137.727
	=	0.00

ZELTIQ Aesthetics's Debt to Equity Ratio for the quarter that ended in Dec. 2016 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	137.727
	=	0.00

ZELTIQ Aesthetics (NAS:ZLTQ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

ZELTIQ Aesthetics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of ZELTIQ Aesthetics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ZELTIQ Aesthetics (ZELTIQ Aesthetics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZELTIQ Aesthetics Inc (NAS:ZLTQ) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.coolsculpting.com

ZELTIQ Aesthetics Inc was incorporated in Delaware in March 2005 as Juniper Medical, Inc. In July 2007, it changed its name to ZELTIQ Aesthetics, Inc. ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled cooling technology platform. Its first commercial product, the CoolSculpting system, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

Executives

Todd Erik Zavodnick	officer: President, International	C/O REVANCE THERAPEUTICS, INC., 7555 GATEWAY BOULEVARD, NEWARK CA 94560
Bradley Hauser	officer: SVP, Research and Development	C/O ZELTIQ AESTHETICS, INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
Danika R Harrison	officer: SVP of Global Marketing	C/O ZELTIQ AESTHETICS, INC. 4410 ROSEWOOD DRIVE PLEASANTON CA 94588
Mark J Foley	director, officer: President and CEO	ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD SUITE 100, PLEASANTON CA 94588
Taylor C. Harris	officer: SVP & Chief Financial Officer	6035 STONERIDGE DRIVE, PLEASANTON CA 94588
Kevin C Oboyle	director	5964 LA PLACE COURT, CARLSBAD CA 92008
Mary Fisher	director	C/O ACORDA THERAPEUTICS, INC., 15 SKYLINE DRIVE, HAWTHORNE NY 10532
D Keith Grossman	director
Andrew N Schiff	director, 10 percent owner	PLANET ZANETT INC, 135 E 57TH ST, NEW YORK NY 10022
Keith J Sullivan	officer: CCO, President, North America	C/O RELIANT TECHNOLOGIES, INC., 464 ELLIS STREET, MOUNTAIN VIEW CA 94043
Patrick F. Williams	officer: SVP & CFO	C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
Leonard C Debenedictis	officer: Chief Technical Officer	C/O RELIANT TECHNOLOGIES, INC., 464 ELLIS STREET, MOUNTAIN VIEW CA 94043
Bryan E Roberts	director	C/O VENROCK ASSOCIATES, 2494 SAND HILL ROAD STE 200, MENLO PARK CA 94025
Jean George	director	CRITICAL THERAPEUTICS INC, 60 WESTVIEW STREET, LEXINGTON MA 02421
Aisling Capital Iii Lp	10 percent owner	888 Seventh Avenue, 30th Fl, New York NY 10106

ZELTIQ Aesthetics (ZELTIQ Aesthetics) Headlines

No Headlines